Particle.news

Download on the App Store

Newsom Pushes State Regulation of PBMs and CalRx Expansion in 2025 Budget Plan

California's governor proposes licensing pharmacy benefit managers and broadening state drug procurement to include name-brand and abortion medications.

Overview

  • Gov. Gavin Newsom has included proposals in the 2025-26 state budget to license and regulate pharmacy benefit managers (PBMs) to increase transparency and curb hidden drug costs.
  • The proposals would require PBMs to report financial and operational data to state agencies and allow audits and penalties for violations.
  • Newsom also seeks to expand the CalRx program, originally focused on generics, to include name-brand drugs like mifepristone to protect abortion access and reduce costs.
  • The measures align with a recent federal executive order directing HHS to negotiate lower drug prices, signaling a coordinated push on prescription affordability.
  • The proposals are set for legislative debate this summer, with Newsom urging lawmakers to approve them as part of the state budget process.